Risk factors
C4 Therapeutics (CCCC) risk factors
Item 1A of every C4 Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors64 risks14 new8 dropped21 reworded
Federal net operating losses increased to $359.6 million alongside expanded R&D tax credit carryforwards of $18.8 million.
Filed Feb 26, 2026 - FY2024 10-K risk factors58 risks
C4 Therapeutics faces ongoing losses, accumulating a deficit of $633.7 million through December 31, 2024.
Filed Feb 27, 2025